GPR12 and neurodegenerative disease: Despite the promising roles of GPR3 (Huang et al., 2015; Capaldi et al., 2018), GPR6, and GPR12 in neurodegenerative diseases, including AD, further research is required to fully elucidate their mechanisms of action and validate them as viable therapeutic targets.